A 16-year-old left-handed male is presented with a history of seizures associated with a fish-like odour and behavioural disturbances thought to be related to trimethylaminuria. His seizures were complex-partial (cursive) seizures and started at the age of 18 months. They occurred in the context of discrete episodes several times per year. The episodes would start with a fish-like odour, followed by seizures occurring in clusters and behavioural disturbance consisting of agitation, mixed affective symptoms, auditory hallucinations and delusions. A urinary assay of trimethylamine (TMA) was elevated, confirming the diagnosis of trimethylaminuria in this patient. He was treated with a choline-restricted diet with resolution of his symptoms. The occurrence of seizures and psychiatric disturbance in this patient was thought secondary to his trimethylaminuria due to the temporal relationship of his seizures and psychiatric disturbance with the odour and his response to treatment. The possible relationship of trimethylaminuria to seizures and to psychiatric disturbance are discussed and a review of the literature presented.
INTRODUCTION
Trimethylaminuria is a disorder of impaired N-oxidation of trimethylamine, characterized by a fish-like odour. People with this disorder secrete the malodorous trimethylamine in their breath, sweat, urine, and other body secretions'. Although seizures' and behavioural disturbance3 have been reported in trimethylaminuria previously, the seizures have been presumed to be an incidental finding and the behavioral disturbance secondary to the psychosocial consequences of the odour4. Presented here is a case of a young boy with trimethylaminuria with seizures and behavioral disturbance temporally related to the development of the fish odour.
CASE REPORT
A 16-year-old left-handed boy presented with a history of periodic seizures associated with severe l/97/040317 + 06 $12.00/O behavioural disturbance. The episodes would last between 1 day and 5 weeks (average 15 days), and started with a characteristic fish-like odour noticed by his family, teachers, and friends, but not by the patient himself. This would often be associated with a tremor, drooling and a sense of elation. His seizures and behavioural disturbance would then start within a few hours to 1 day after the onset of the odour. The seizures would occur in clusters during these episodes. They would start with an epigastric sensation, abdominal pain and nausea; the right arm would then stiffen, and he would then be seen to be staring with lip smacking, and confusion. This would be followed by running and at times a severe headache. His behavioural disturbance had three phases: (1) a period of being agitated, aggressive, not sleeping with auditory and/or visual hallucinations; (2) tin anxious phase with panic symptoms and repetitive movements of his arms, e.g. chopping; and (3) hyperphagia and hypersomnolence.
Also of 0 1997 British Epilepsy Association note, were concerns expressed by his teachers and mother of a gradual cognitive decline.
Past history
His past medical history was remarkable for an episode of apparent Sydenham's chorea at age 8. During that time, he had severe chorea over a 2-month period resolving with haloperidol. At the time, he was also diagnosed with mitral valve prolapse. His seizures began at age 18 months, but initially occurred nocturnally only and were felt to be night terrors. His seizure disorder was then diagnosed with telemetry at age 6, but he had few seizures until the age of 9, shortly after his admission for chorea. These were thought initially to be due to treatment with haloperidol and he was not treated with antiepileptic drugs (AEDs) until the age of 11, when he was started on carbamazepine. He has no history of drug, alcohol or tobacco abuse. His past psychiatric history is remarkable for his diagnosis with night terrors at age 18 months, thought to be likely nocturnal seizures in retrospect. His behavioural episodes also began at 18 months, but were mild and infrequent until he reached puberty at age 9. From age 9 to age 16, he would have four to five such episodes per year, prompting one or two psychiatric admissions per year related to these episodes with a variety of diagnoses, including bipolar disorder, schizophrenia, depression, intermittent explosive disorder, organic hallucinosis, adjustment disorder with mixed disturbance of emotions and conduct, organic delusional syndrome, organic personality disorder, developmental disorder nos, anxiety disorder nos, panic disorder, other specified family circumstances, psychosis nos, and attention deficit disorder with hyperactivity. His previous treatments included haloperidol, various other neuroleptics, phenytoin, imipramine, other tricyclics, lithium, and behavioural therapy, all without effect. Lithium and phenytoin were felt to have exacerbated his symptoms.
His birth and developmental history are remarkable for a pregnancy complicated only by severe morning sickness and treated with Benedictin in the first trimester. He was the product of a full-term vaginal delivery with forceps, following 21 hours of labour, and weighed 8 lb 8 oz. As an infant, he had frequent colic, difficulty feeding and cried excessively. He sat at 6 months, walked at 9 months, but had difficulty with fine motor skills. His language milestones were delayed, with four to five words at age 3; years, sentences at age 6 years and difficulties with articulation. His receptive language was suspected as being problematic as an infant and his hearing tested as normal at age 3. He was toilet trained for bowel at age 3 years 4 months and for bladder at 3 years 7 months. He entered a specialized preschool at age 3, and an outpatient rehabilitation school program at age 5, which he is still attending. He has had academic problems throughout his schooling especially in reading and in arithmetic.
His behavioural problems, as discussed above, were prominent at school as well as at home. In between these discrete episodes, however, he otherwise has had very good relations with teachers and peers. He describes his childhood as being 'happy' despite the odour, seizures, and behavioural problems. The odour was present but was not a major problem until the age of 9. Of note is that he had an early onset of puberty at age 9, following his episode of chorea and coinciding with the exacerbation of his seizures and behavioural disturbances.
His family history is remarkable for his mother, age 36, with 'bleeding tendencies', his oldest brother with learning difficulties requiring special reading classes, a half sister with a history of depression, a maternal second cousin with generalized tonic-clonic seizures, a paternal aunt and uncle also with generalized tonic-clonic seizures, a maternal great grandfather with Sydenham's chorea, a paternal grandfather with throat cancer, a paternal grandmother with Alzheimer's, and multiple family members with a history of myocardial infarction. He is the oldest of four, with two brothers, ages 13 and 8 and one sister, age 4. He reports good relations with his siblings and parents. His father died at age 67 of a myocardial infarction when the patient was age 12.
Mental state examination On examination at admission, he appeared a pleasant, cooperative 16-year-old white male, casually dressed, appearing moderately anxious and agitated during the interview. He spoke with a marked dysarthria and a mild dysprosody; his rate of speech was slow. He was noted to be fidgeting throughout the interview, with some pacing, but had no evidence of a movement disorder. He appeared agitated and described feeling 'down' and irritable. He had no diurnal variation of his mood, and no thoughts of harm to himself or others. His sleep was markedly decreased, averaging 2 hours per night over the 2 weeks prior to presentation, and he had a decreased appetite with a 5 lb weight loss. He did, however, have a maintained interest in his hobbies over this time. There was no evidence of loosening of associations, thought insertion or withdrawal and no delusions or obsessions. He expressed concern over voices which he heard 'as if' they were coming from people inside him. He described hearing the voices of Luke Skywalker and Darth Vadar fighting inside him. The voice of Luke Skywalker was telling him to go home. He had no visual, olfactory, gustatory, or tactile hallucinations on admission but described previous visual hallucinations (visions of devils) occurring during past episodes. He was alert and oriented and his attention was good, with digit recall intact, and serial 7s intact. He was able to recall two of three objects at 5 minutes and able to cite current and past presidents to Reagan. He demonstrated concrete proverb interpretation and was able to do simple arithmetic without difficulty, as well as to copy a circle and a square. He had reasonable insight, stating that he realized he was ill and commencing one of his 'bad spells' at the time of the interview. His neurological examination was intact.
Investigations
He had numerous blood and urine examinations, including LETS, TFTs, electrolytes, and FBS, as well as porphyria, organic acid and inborn error of metabolism screens which were all negative. He was karyotyped as a 46, XY normal male and his awake EEG showed medium voltage slow waves in the 4-6 HZ frequency seen independently from both temporal regions interictally. He also had telemetry showing spike and wave activity in both temporal regions. His CT scan and MRI scan were both normal. His urinary TMA level was elevated at 121 pg/ml (after choline challenge). 'This confirmed the diagnosis of trimethylaminuria, and treatment with dietary restriction was begun at age 16. His performance He has had an excellent response to dietary therapy with good adherence to a choline restricted diet. Since starting the diet 1 year ago, he has had only two brief episodes of seizures and behavioural disturbance each lasting several hours and a good response as well with respect to the odour. Both episodes were associated with identified dietary indiscretions preceding them. His seizures had been refractory to treatment prior to starting the diet, but are now well controlled on carbamazepine 400 mg tds. His response in terms of improvement in cognitive function is difficult to assess at this early stage. He does have some subjective improvement cognitively and has enrolled in a more academically oriented school program recently. His scores on the WAIS-R are encouraging but difficult to interpret as the scores cannot be directly compared to the WISC scores, without the results of the various sub-scales.
DISCUSSION
This is a 16-year-old white male with trimethylaminuria presenting with episodes of a fish-like odour associated with complex-partial (cursive) seizures and a mixed affective state with and without auditory hallucinations and delusions. He responded well to treatment with dietary restriction of choline. This case represents the second case where seizures have been reported in trimethylaminuria and is one of several case reports on psychiatric disturbance associated with the disorder. The relationship of this patient's seizures and behavioural disturbance to the development of the fish odour, occurring in discrete episodes, raises the possibility of these aspects of the illness being related to the defect in N-oxidation of trimethylamine, as opposed to being unrelated symptoms or related to a purely psychosocial reaction to the development of the odour itself. Certainly the latter explanation cannot be entirely excluded, with respect to his behavioural disturbance. However, the patient did not express any concern himself about the odour and the development of delusions and hallucinations would represent an unusual presentation of such a reaction. The possibility of his behaviour being related to a postictal state was also considered, but there was no clear temporal relation of the psychiatric disturbance to his seizures.
Trimethylaminuria was first described clinically in 19705 and there have since been over 40 cases reported in the literature. The possession of a relatively inefficient form of flavin-containing monooxygenase (thought to be FM03)6, inherited in an autosomal recessive fashion, leads to the decreased metabolic conversion of dietaryderived odorous trimethylamine to the nonodorous trjmethylamine N-oxide. Excess trimethylamine is consequently eliminated in the urine (trimethylaminuria), breath, sweat and other bodily secretions, thereby imparting a strong fish-like odour to the patient'. Clinical diagnosis may be confirmed by the finding of an increased urinary trimethylamine level and/or decreased trimethylamine N-oxide using gasliquid chromatography either with or without a previous choline or trimethylamine challenge'V7*". Treatment usually involves restricting the intake of dietary trimethylamine precursors (e.g. trimethylamine N-oxide, choline) and the occasional use of antibiotics to decrease the bacterial liberation of trimethylamine from these precursors within the gut has also been suggested2.
A similar disorder in chickens fed rapeseed meal has been linked to both genetic decrease in trimethylamine-N-oxidase and dietary intake of inhibitors of this enzyme: a tannin (polyphenolic) fraction and 5-vinyloxazolidine-2-thione (OZT) derived from progoitrin.
Although not yet proven for humans with trimethylaminuria, avoidance of dietary OZT (high in the brassicas, pepper spice, horseradish) and tannins (high in teas and coffees) may also assist in odour reduction". Trimethylaminuria has been associated in the literature with several congenital problems including Noonan's (Ullrich's) syndrome5, PraderWilli syndrome", onychodystrophy" and other situations such as hepatic'2*'3 and renal disease'4*'5 , viral infectionI and copper deficiency coupled with premature birth".
Nevertheless, several cases have been cited in otherwise healthy individuals with no associated clinical problems and it is now generally accepted that this odour production is a separate phenomenon and has been designated the 'fish-odour syndrome'.
However, in terms of neuropsychiatric aspects of trimethylaminuria, there is one case report which describes mental retardation and selfabusive behaviour" and another where seizures and encephalopathy were apparent, although these latter events were thought to be unrelated to the development of trimethylaminuria2.
Several psychiatric disturbances have been reported in patients and these have been presumed to be psychosocial reactions to the odour. Feelings of shame, low self-esteem, social isolation, anxiety, depression, suicidal tendencies, paranoia, educational and career disadvantages, relationship difficulties, addiction to alcohol and other drugs and overt aggression have all been described',3.4.
Speculation as to a causative linkage between neurological disorders and deficient trimethylamine N-oxidation could occur along several lines. Increased blood levels of trimethylamine, together with other amines, are thought to play a role in the neurological dysfunction, encephalopathy and coma observed in hepatic and renal disease. Such elevated trimethylamine levels are found in patients with impaired hepatocellular function and in those possessing portosystemic shunts following treatment for cirrhosis, where the first-pass metabolism and consequent extraction of trimethylamine absorbed from the gastrointestinal tract will be decreased'2*'3. Similarly, in uraemic patients, the abnormal overgrowth of bacteria in the small intestine greatly increases the liberation of trimethylamine from dietary precursors and, compounded with reduced kidney function and subsequent decreased renal clearance, leads to elevated blood levels of this aminet4~". Alternatively, the overproduction and accumulation or trimethylamine may be coincidental, reflecting an inefficiently functioning flavin-containing monooxygenase which may have other as yet unknown metabolic roles, perhaps within the brain itself. Secondary modulating influences such as steroid hormone levels'", dietary enzyme inhibitors" or even trimethylamine itself as a competing substrate, may further suppress the already low enzyme activity, thereby precipitating problems. The effect of testosterone on N-oxidation'" may explain this patient's exacerbation of symptoms at puberty.
N-oxidation of TMA is likely polymorphic2'.
The impairment of N-oxidation may, furthermore, be much more common than has been considered in the past, and the effects of such an impairment on other substances undergoing N-oxidation (e.g. metapyrone, guanethidine, nicotine, nicotinamide, pinacidil) is not known20,2'. Further studies of the direct and indirect CNS effects of trimethylamine, the possible role of the flavin-containing monooxygenase system within the CNS and the clinical callsequences of its dysfunction as well as the effects of secondary modulating influences are needed. This case of a young boy with trimethylaminuria presenting with episodic seizures and behavioral disturbance temporally related to the development of the fish odour and responding to treatment with a choline-restricted diet raises some questions about the clinical spectrum of this disorder and the possible CNS effects of trimethylamine. Seizures have been reported in one previous case of trimethylaminuria and psychiatric disturbance are relatively common in this disorder. Both have been assumed to be unrelated to the pathogenesis of trimethylaminuria, however. This case suggests that not all of the psychiatric disturbances seen in this disorder are necessarily related to a psychosocial reaction to the odour itself. The temporal relationship of this patient's seizures with his odour and the response to treatment also bring to question the possibility that neuropsychiatric manifestations can be related to trimethylaminuria.
In this context, it is interesting to note that in the early nineteenth century, odour was considered to be an important sign of psychiatric illness: "the breath of maniacal persons has been remarked by Esquirol and other practical authors to exhale a fetid smell, which some compare to that of stinking fish."'2 A multicentre study to look at the clinical spectrum of trimethylaminuria is currently underway.
